首页 › 肺癌 › 哥伦比亚特区 › Washington
Washington DC 肺癌临床试验
41项针对 肺癌的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- George Washington University Medical Center, Washington D.C.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- 以及另外 1 项
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
招募中3 期
- George Washington University Medical Center, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Washington D.C.
Collection of Blood From Patients With Cancer
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Maryland Oncology Hematology, P.A., Silver Spring · 距离 7 英里
- Maryland Oncology Hematology, P.A., Bethesda · 距离 7 英里
- Maryland Oncology Hematology, P.A., Largo · 距离 11 英里
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
招募中1/2 期
- MedStar Georgetown University Hospital, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- National Institutes of Health, Bethesda · 距离 7 英里
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
招募中1 期
- Maryland Oncology Hematology, Calverton · 距离 12 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
招募中1 期
- Georgetown University, Washington D.C.
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 距离 11 英里
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
招募中1/2 期
- Georgetown University Medical Center, Washington D.C.
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 距离 11 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 距离 11 英里
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中观察性研究欢迎健康志愿者
- Cancer Support Community Research & Training Institute, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Sibley Memorial Hospital, Washington D.C.
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
招募中3 期
- The George Washington University Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
招募中2 期
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Erector Spinae Block for Thoracic Surgery
招募中4 期
- The George Washington University, Washington D.C.
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
招募中观察性研究
- MedStar Georgetown University Hospital, Washington D.C.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Silver Spring · 距离 7 英里
- Massive Bio SYNERGY-AI site, Bethesda · 距离 7 英里
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
招募中欢迎健康志愿者
- MedStar Health, Washington D.C.
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Arlington, VA41 项研究
- Chicago, IL41 项研究
- Baltimore, MD40 项研究
- Nashville, TN40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
- Seattle, WA33 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
- 淋巴瘤23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。